Literature DB >> 11936490

Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis.

A H C van der Meijs1, I L Tan, F Barkhof.   

Abstract

The purpose of this study is to review the incidence of contrast enhancement of the trigeminal nerve on magnetic resonance imaging (MRI) in a large cohort of patients with multiple sclerosis (MS). MRI scans of 851 MS patients participating in a phase III clinical trial were reviewed for the presence of gadolinium enhancement on postcontrast T1-weighted images. If enhancement was present, it was documented whether this involved only the proximal or also the distal part of the fifth nerve, and whether the abnormality was unilateral or bilateral. In 24 (2.8%) patients, enhancement of the trigeminal nerve was observed, and was bilateral in 16 (66.7%) of those. In 19 (79.2%) patients with abnormal nerves, enhancement extended to the distal part of the trigeminal nerve (into Meckel's cave). The results of this study indicate a high, probably clinically silent, incidence of trigeminal nerve demyelination in MS and frequent involvement of the peripheral type of myelin in MS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936490     DOI: 10.1191/1352458502ms775oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3 T.

Authors:  R J Mills; C A Young; E T Smith
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

Review 2.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

Review 3.  Trigeminal neuralgia: diagnosis and treatment.

Authors:  William P Cheshire
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

4.  Peripheral third cranial nerve enhancement in multiple sclerosis.

Authors:  M Tariq Bhatti; Ilona M Schmalfuss; Lorna S Williams; Ronald G Quisling
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

5.  Cranial nerve involvement in patients with MOG antibody-associated disease.

Authors:  Alvaro Cobo-Calvo; Xavier Ayrignac; Philippe Kerschen; Philippe Horellou; Francois Cotton; Pierre Labauge; Sandra Vukusic; Kumaran Deiva; Ché Serguera; Romain Marignier
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-02-01

Review 6.  Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology.

Authors:  Ellen Oudejans; Antonio Luchicchi; Eva M M Strijbis; Jeroen J G Geurts; Anne-Marie van Dam
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-11-24

7.  The Distributional Characteristics of Multiple Sclerosis Lesions on Quantitative Susceptibility Mapping and Their Correlation With Clinical Severity.

Authors:  Zhuoxin Guo; Liu Long; Wei Qiu; Tingting Lu; Lina Zhang; Yaqing Shu; Ke Zhang; Ling Fang; Shaoqiong Chen
Journal:  Front Neurol       Date:  2021-07-09       Impact factor: 4.003

8.  Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease.

Authors:  Lukas Haider; Wei-Shin Evelyn Chan; Elisabeth Olbert; Stephanie Mangesius; Assunta Dal-Bianco; Fritz Leutmezer; Daniela Prayer; Majda Thurnher
Journal:  Front Neurol       Date:  2019-11-06       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.